Published in:
Open Access
01-08-2020 | Schizophrenia | Editorial
Impact of the metabolic syndrome on severe mental disorders
Authors:
Andrea Schmitt, Daniela Reich-Erkelenz, Peter Falkai
Published in:
European Archives of Psychiatry and Clinical Neuroscience
|
Issue 5/2020
Login to get access
Excerpt
Compared to the general population, severe psychiatric disorders are associated with an increased mortality, which can largely be explained by a high incidence of somatic comorbidities, unhealthy lifestyle, low physical activity and increased rate of suicides [
1]. For example, schizophrenia patients have a higher prevalence of the metabolic syndrome than the general population, with a two- to threefold increased risk for cardiovascular diseases (CVDs) resulting in increased cardiac mortality [
2]. This leads to an estimated reduction in life expectancy of nearly 10–15 years compared to the general population. The metabolic syndrome is defined as a combination of increased waist circumference and two of the following criteria: high blood pressure, elevated triglycerides, low high-density lipoprotein (HDL) cholesterol and elevated fasting glucose, by the International Diabetes Federation. It is also defined by the Adult Treatment Panel III (ATP III) of the National Cholesterol Education and the adapted Adult Treatment Panel III (ATP III-A) of the American Heart Association, which require 3 criteria to be fulfilled [
1]. …